These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 5853161)

  • 21. Advances in portal hypertension.
    McCormick A; Qasim A
    Med J Malaysia; 2005 Jul; 60 Suppl B():6-11. PubMed ID: 16108165
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacological treatment of portal hypertension.
    González-Abraldes J; Bosch J; García-Pagán JC
    Curr Opin Investig Drugs; 2001 Oct; 2(10):1407-13. PubMed ID: 11890356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of extrahepatic vasodilation in portal hypertension.
    Hennenberg M; Trebicka J; Sauerbruch T; Heller J
    Gut; 2008 Sep; 57(9):1300-14. PubMed ID: 18445644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Portal hypertensive gastropathy in cirrhosis].
    Møller S; Becker PU; Henriksen JH
    Ugeskr Laeger; 1993 May; 155(19):1480-1. PubMed ID: 8316979
    [No Abstract]   [Full Text] [Related]  

  • 25. Role of endothelin in systemic and portal resistance in cirrhosis.
    Angus PW
    Gut; 2006 Sep; 55(9):1230-2. PubMed ID: 16905694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of phentolamine on portal pressure in cirrhotic patients with portal hypertension].
    Zhu J; Leng X; Yin J
    Zhonghua Wai Ke Za Zhi; 1997 Feb; 35(2):92-4. PubMed ID: 10374485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hemodynamic disorders due to liver cirrhosis].
    Garbuzenko DV
    Klin Med (Mosk); 1996; 74(2):5-7. PubMed ID: 8772089
    [No Abstract]   [Full Text] [Related]  

  • 28. [Rheologic changes of blood in portal hypertension].
    Apsatarov EA; Andreev GN; Liubinskiĭ VL; Riudiger PE; Mukhamedzhanov GK; Ibadildin AS
    Khirurgiia (Mosk); 1994 Feb; (2):33-6. PubMed ID: 8028244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Theoretical and practical considerations in the treatment of portal hypertension secondary to hepatic cirrhosis.
    Bizer LS
    Am Surg; 1984 Oct; 50(10):524-9. PubMed ID: 6385791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial.
    Abraldes JG; Albillos A; Bañares R; Turnes J; González R; García-Pagán JC; Bosch J
    Gastroenterology; 2009 May; 136(5):1651-8. PubMed ID: 19208350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Splanchnic and systemic vasodilatation: the patient.
    Tsai MH
    J Clin Gastroenterol; 2007; 41 Suppl 3():S266-71. PubMed ID: 17975476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of portal hemodynamics.
    Viallet A; Huet PM; Marleau D; Villeneuve JP
    Gastroenterology; 1980 Sep; 79(3):603-5. PubMed ID: 7429127
    [No Abstract]   [Full Text] [Related]  

  • 33. [Acceleration of intestinal motility in patients with liver cirrhosis and portal hypertension].
    Mate Jiménez J; Pajares García JM
    Rev Esp Enferm Apar Dig; 1973 Jun; 40(6):633-6. PubMed ID: 4732127
    [No Abstract]   [Full Text] [Related]  

  • 34. Portal hypertensive hemorrhage: pathogenesis and risk factors.
    Boyer TD
    Semin Gastrointest Dis; 1995 Jul; 6(3):125-33. PubMed ID: 7551969
    [No Abstract]   [Full Text] [Related]  

  • 35. [Nitric oxide, vasodilatation and cirrhosis: a double (dys)equilibrium].
    Sogni P; Moreau R; Lebrec D
    Gastroenterol Clin Biol; 1999 Jan; 23(1):101-4. PubMed ID: 10219610
    [No Abstract]   [Full Text] [Related]  

  • 36. Pathogenesis of ascites in cirrhosis and portal hypertension.
    Heneghan MA; Harrison PM
    Med Sci Monit; 2000; 6(4):807-16. PubMed ID: 11208415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salviae miltiorrhizae ameliorates cirrhosis and portal hypertension by inhibiting nitric oxide in cirrhotic rats.
    Wang H; Chen XP; Qiu FZ
    Hepatobiliary Pancreat Dis Int; 2003 Aug; 2(3):391-6. PubMed ID: 14599946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of losartan, an angiotensin II receptor antagonist, on portal pressure in cirrhosis.
    Schneider AW; Kalk JF; Klein CP
    Hepatology; 1999 Feb; 29(2):334-9. PubMed ID: 9918907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathophysiology and management of portal hypertension. 2: Cirrhotic ascites.
    Stanley AJ; Bouchier IA; Hayes PC
    Br J Hosp Med; 1997 Jul 9-Aug 19; 58(2-3):74-8. PubMed ID: 9349370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlations of portal hypertensive gastropathy of hepatitis B cirrhosis with other factors.
    Pan WD; Xun RY; Chen YM
    Hepatobiliary Pancreat Dis Int; 2002 Nov; 1(4):527-31. PubMed ID: 14607680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.